MRSA vaccine: Bavarian Nordic to collaborate with Evaxion Biotech
by Press Release from Outbreak News Today on (#130JP)
Bavarian Nordic A/S announced Thursday that it has entered into a joint collaboration with Evaxion Biotech, a Danish biotechnology company, and Technical University of Denmark (DTU), for the development of an MVA-BN-based vaccine against MRSA (Methicillin-resistant Staphylococcus aureus) using Evaxion's computer-based technology to discover novel antigens. The same approach could potentially be used to target ["]
